Complete FDA and NHTSA recall records dated in December 2016.
These records include useful source details for the selected month.
CGMP Deviations; deficiencies at the manufacturer may result in assay or content uniformity failures
Presence of Foreign Tablets/Capsules; report of Amlodipine Tablets found in 1000 count bottles of Metformin Hydrochloride Tablets USP
CGMP Deviations: manufactured under practices which may result in assay or content uniformity failures.
CGMP Deviations; deficiencies at the manufacturer may result in assay or content uniformity failures
CGMP Deviations; deficiencies at the manufacturer may result in assay or content uniformity failures
Microbial Contamination of Non-Sterile Product
CGMP Deviations; deficiencies at the manufacturer may result in assay or content uniformity failures
CGMP Deviations: manufactured under practices which may result in assay or content uniformity failures.
CGMP Deviations; deficiencies at the manufacturer may result in assay or content uniformity failures
Lack of Assurance of Sterility; damage to the internal portion of the dropper tip portion of the container
CGMP Deviations: manufactured under practices which may result in assay or content uniformity failures.
Use this page to compare the recalls reported during the month, then open an individual record for the exact reason, classification, company, remedy or distribution information available from the official source. Monthly counts are descriptive, not a safety rating.
